Concerns are growing as the proportion of consignment production is high in HBP treatment "Losartan" formulation, which is known to have excess Azido-based impurities. If it appears as an impurity problem at the raw material stage, there is a possibility that many pharmaceutical companies tied up with consignment will start collecting products.

According to the Ministry of Food and Drug Safety on the 22nd, in the case ofLosartan 50mg, 16 companies in Korea manufacture it, but the number of licensed products is 88. 72 pharmaceutical companies are entrusting manufacturing to other companies. The factory that manufactures the most items is Withus Pharmaceutical's Anseong Plant 1, which produces a total of